Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13cyclopia sequence 7Neoplasms 6Multiple Myeloma 6Fatigue 6Neoplasms, Plasma Cell 5Neoplasm Metastasis 4Lung Neoplasms 4Dyspnea 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Uterine Cervical Neoplasms 3Tobacco Use Cessation 3Prostatic Neoplasms 3Primary Myelofibrosis 3Leukemia 3Head and Neck Neoplasms 3Depression 3Carcinoma, Renal Cell 3Vomiting 2Smoking Cessation 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Parasomnias 2Pancreatic Neoplasms 2Pain 2Osteosarcoma 2Kidney Neoplasms 2Hodgkin Disease 2Hematologic Neoplasms 2

Interventions

Surveys and Questionnaires 2Analgesics, Opioid 2trimebutine 3-thiocarbamoylbenzenesulfonate 1acetaminophen, aspirin, caffeine drug combination 1Uterine Myomectomy 1Transcutaneous Electric Nerve Stimulation 1Therapeutics 1Tea 1Tapentadol 1Saline Solution 1Ropivacaine 1Propofol 1Nerve Block 1Meperidine 1Lidocaine 1Ketamine 1Injections, Subcutaneous 1Fentanyl 1Anesthetics, Local 1Anesthesia, Local 1Anesthesia, General 1Analgesia, Patient-Controlled 1Acupuncture Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Agnosia × Surveys and Questionnaires × Clear all
NCT02514252 2021-05-18

Sublingual Fentanyl for the Management of Breakthrough Pain

M.D. Anderson Cancer Center

Phase 2 Terminated
6 enrolled 8 charts

Agnosia, Neoplasm Metastasis, Recurrence

NCT01438476 2020-02-12

Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas

M.D. Anderson Cancer Center

Phase 3 Completed
178 enrolled 9 charts
Gastrointestinal

Agnosia, Liver Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡